Joffe Ari, Vázquez-Maldonado Nancy, Singleton Kentner L, Leitner Wolfgang W
Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Trends Pharmacol Sci. 2024 Dec;45(12):1097-1099. doi: 10.1016/j.tips.2024.10.011. Epub 2024 Nov 8.
Screening small molecule (SM) libraries now replaces traditional methods for vaccine adjuvant discovery. A study by Soni et al. highlights the use of primary human cells in high-throughput screening (HTS), leading to the discovery of a novel SM TLR7/8 agonist, PVP-037. This compound successfully restored vaccine-induced immune responses in aged mice.
筛选小分子(SM)文库如今已取代了传统的疫苗佐剂发现方法。索尼等人的一项研究强调了在高通量筛选(HTS)中使用原代人类细胞,从而发现了一种新型的小分子Toll样受体7/8(TLR7/8)激动剂PVP-037。该化合物成功恢复了衰老小鼠中疫苗诱导的免疫反应。